• 1. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 2. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 3. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

Comprehensive Overview of (2-Methoxypyridin-4-yl)methanamine Dihydrochloride (CAS No. 1029689-75-5)

(2-Methoxypyridin-4-yl)methanamine dihydrochloride (CAS No. 1029689-75-5) is a chemically significant compound widely utilized in pharmaceutical research and organic synthesis. This compound, characterized by its pyridine backbone and methoxy functional group, has garnered attention for its potential applications in drug development, particularly in the design of small molecule inhibitors and biologically active agents. Its molecular structure, featuring a primary amine group, makes it a versatile intermediate for constructing more complex molecules.

In recent years, the demand for high-purity chemical intermediates like (2-Methoxypyridin-4-yl)methanamine dihydrochloride has surged, driven by advancements in medicinal chemistry and preclinical research. Researchers frequently search for CAS 1029689-75-5 suppliers, synthesis methods, and analytical data to ensure reproducibility in their experiments. The compound’s role in kinase inhibitor development has also been a focal point, aligning with the growing interest in targeted cancer therapies and personalized medicine.

The physicochemical properties of (2-Methoxypyridin-4-yl)methanamine dihydrochloride include a white to off-white crystalline appearance, solubility in water and polar organic solvents, and stability under standard laboratory conditions. These traits make it suitable for high-throughput screening and structure-activity relationship (SAR) studies. Analytical techniques such as HPLC, NMR, and mass spectrometry are commonly employed to verify its purity and identity, addressing the need for quality control in research settings.

From an industrial perspective, the scalability of (2-Methoxypyridin-4-yl)methanamine dihydrochloride synthesis is a critical consideration. Optimized routes often involve reductive amination or protective group strategies to enhance yield and minimize byproducts. Discussions around green chemistry and sustainable synthesis have further influenced its production, with researchers exploring catalytic methods and solvent-free reactions to reduce environmental impact.

Emerging trends in AI-driven drug discovery have also spotlighted compounds like CAS 1029689-75-5, as machine learning models increasingly rely on well-characterized building blocks for virtual screening. This intersection of computational chemistry and experimental validation underscores the compound’s relevance in modern research. Additionally, its potential in neuropharmacology—particularly in modulating G-protein-coupled receptors (GPCRs)—has sparked interest in central nervous system (CNS) drug development.

In summary, (2-Methoxypyridin-4-yl)methanamine dihydrochloride (CAS No. 1029689-75-5) represents a pivotal tool in contemporary chemical and pharmaceutical research. Its applications span drug design, material science, and bioconjugation, reflecting its adaptability to diverse scientific challenges. As the demand for precision medicine and innovative therapeutics grows, this compound will likely remain a cornerstone in the quest for novel bioactive molecules.

• 148900-69-0((2-Methoxypyridin-4-yl)methanamine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)